References
- Abdul Basit S, Dawood A, Ryan J, Gish R. Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection. Expert Rev Clin Pharmacol. 2017 Jul 03;10(7):707–716. https://doi.org/10.1080/17512433.2017.1323633
- Agarwal K, Fung SK, Nguyen TT, Cheng W, Sicard E, Ryder SD, Flaherty JF, Lawson E, Zhao S, Subramanian GM, et al. Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection. J Hepatol. 2015 Mar;62(3):533–540. https://doi.org/10.1016/j.jhep.2014.10.035
- Aghasadeghi MR, Aghakhani A, Mamishi S, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Karami A, Bavand A, Ramezani A. No evidence of occult HBV infection in population born after mass vaccination. Wien Med Wochenschr. 2020 Jun; 170(9–10):218–223. https://doi.org/10.1007/s10354-020-00748-z
- Al-Qahtani AA, Al-Anazi MR, Nazir N, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, et al. The correlation between hepatitis B virus Precore/core mutations and the progression of severe liver disease. Front Cell Infect Microbiol. 2018 Oct 22;8:355. https://doi.org/10.3389/fcimb.2018.00355
- Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B virus molecular epidemiology, host virus interaction, co infection, and laboratory diagnosis in the MENA Region: an Update. Pathogens. 2019 May 11;8(2):63. https://doi.org/10.3390/pathogens8020063
- Ambachew H, Zheng M, Pappoe F, Shen J, Xu Y. Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia. PLoS One. 2018 Feb 20;13(2):e0193177. https://doi.org/10.1371/journal.pone.0193177
- Arikan A, Şanlidağ T, Süer K, Sayan M, Akçali S, Güler E. [Molecular epidemiology of hepatitis B virus in Northern Cyprus] (in Turkish). Mikrobiyol Bul. 2016 Jan 7;50(1):86–93. https://doi.org/10.5578/mb.10292
- Arikan A, Sayan M, Sanlidag T, Suer K, Akcali S, Guvenir M. Evaluation of the pol/S gene overlapping mutations in chronic hepatitis B patients in Northern Cyprus. Pol J Microbiol. 2019 Sep; 68(3):317–322. https://doi.org/10.33073/pjm-2019-034
- Arikan A, Sayan M. Comparison of Qiagen and Iontek hepatitis B virus DNA polymerase chain reaction quantification kits in chronic hepatitis B patients infected with hepatitis B genotype D. Viral Hepat J. 2020 Apr 28;26(1):9–13. https://doi.org/10.4274/vhd.galenos.2020.2019.0024
- CDC. Interpretation of hepatitis B serological test results [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2005 [cited 2020]. Available from https://www.cdc.gov/HEPATITIS/HBV/PDFs/SerologicChartv8.pdf
- CDC. Morbidity and mortality weekly report recommendations and report. Centers for Disease Control and Prevention. 2018;67(1):1–32.
- CDC. Interpretation of hepatitis B serological tests results [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2020a [cited 2020 Mar]. Available from https://www.cdc.gov/hepatitis/hbv/index.htm
- CDC. Hepatitis B questions and answers for public health professionals [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2020b [cited 2020 Mar]. Available from https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm
- CDC. Immunization schedules [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2020c [cited 2020 Feb]. Available from https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent. html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccin es%2Fschedules%2Fhcp%2Fchild-adolescent.html
- CDC. Interpretation of hepatitis B serological Tests results [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2020d [cited 2020 Mar]. Available from https://www.cdc.gov/hepatitis/hbv/index.htm
- Chan HL, Wang H, Niu J, Chim AM, Sung JJ. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial. Antivir Ther. 2007;12(3): 345–353.
- Cholongitas E, Haidich AB, Apostolidou-Kiouti F, Chalevas P, Papatheodoridis GV. Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review. Ann Gastroenterol. 2018;31(4):480–490. https://doi.org/10.20524/aog.2018.0266
- Cooksley WGE, Piratvisuth T, Lee SD, Mahachai V, Chao YC, Tanwandee T, Chutaputti A, Chang WY, Zahm FE, Pluck N. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat. 2003 Jul;10(4):298–305. https://doi.org/10.1046/j.1365-2893.2003.00450.x
- de Almeida RW, Espírito-Santo MP, Sousa PSF, de Almeida AJ, Lampe E, Lewis-Ximenez LL. Hepatitis B virus DNA stability in plasma samples under short-term storage at 42°C. Braz J Med Biol Res. 2015 Jun;48(6):553–556. https://doi.org/10.1590/1414-431x20144040
- Dini G, Toletone A, Barberis I, Debarbieri N, Massa E, Paganino C, Bersi F, Montecucco A, Alicino C, Durando P. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother. 2017 Feb;13(2):440–444. https://doi.org/10.1080/21645515.2017.1264788
- Dynavax. Hepatitis B Recombinant vaccine [Internet]. 2018 [cited 2018 Feb]. Available from https://investors.dynavax.com/static-files/f93ec0ea-c184-4afb-b2d6-98ebd0030a79
- EASL. HBV 2017 Clinical practice guidelines on the management of hepatitis B virus infection [Internet]. Geneva (Switzerland): European Association for the Study of the Liver; 2017 [cited 2020 Mar]. Available from https://easl.eu/wp-content/uploads/2018/10/HepB-English-report.pdf
- FDA. Hepatitis B [Internet]. Silver Spring (USA): Food and Drug Administration; 2019 [cited 2019 Apr 9]. Available from https://www. fda.gov/vaccines-blood-biologics/blood-donor-screening/hepatitis-b
- Fletcher GJ, Eapen CE, Abraham P. Hepatitis B genotyping: the utility for the clinicians. Indian J Gastroenterol. 2019 Oct 15;39(4): 315–320. https://doi.org/10.1007/s12664-019-00995-y
- Ganczak M, Topczewska K, Budnik-Szymoniuk M, Korzeń M. Seroprevalence of anti-HBc, risk factors of occupationally acquired HBV infection and HBV vaccination among hospital staff in Poland: a multicenter study. BMC Public Health. 2019 Dec;19(1):298. https://doi.org/10.1186/s12889-019-6628-1
- Gilead Sciences. Prescribing information: VEMLIDY® (tenofovir alafenamide) [Internet]. Foster City (USA): Gilead Sciences; 2015 [cited 2020 Sep]. Available from https://www.gilead.com/-/media/files/pdfs/medicines/liver-disease/vemlidy/vemlidy_pi.pdf
- Gilman C, Heller T, Koh C. Chronic hepatitis delta: A state-of-the-art review and new therapies. World J Gastroenterol. 2019 Aug 28; 25(32):4580–4597. https://doi.org/10.3748/wjg.v25.i32.4580
- HBF. About the Hepatitis B Foundation. Doylestown (USA): Hepatitis B Foundation; 2018a [cited 2020 Sep 3]. Available from https://www.hepb.org/assets/Uploads/About-the-Hepatitis-B-Foundation-Fact-Sheet-final-8-28-18.pdf
- HBF. Hepatitis B test [Internet]. Doylestown (USA): Hepatitis B Foundation; 2018b [cited 2020 Sep 3]. Available from https://www. hepb.org/prevention-and-diagnosis/diagnosis/hbv-blood-tests
- Ho EY, Yau T, Rousseau F, Heathcote EJ, Lau GKK. Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy. Hepatol Int. 2015 Apr;9(2):224–230. https://doi.org/10.1007/s12072-015-9612-6
- Huang D, Lin T, Wang S, Cheng L, Xie L, Lu Y, Chen M, Zhu L, Shi J. The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China. BMC Infect Dis. 2019 Dec;19(1):878. https://doi.org/10.1186/s12879-019-4459-4
- Hyun Kim B, Ray Kim W. Epidemiology of hepatitis B virus infection in the United States. Clin Liver Dis (Hoboken). 2018 Jul;12(1): 1–4. https://doi.org/10.1002/cld.732
- Innaimo SF, Seifer M, Bisacchi GS, Standring DN, Zahler R, Colonno RJ. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 1997 Jul;41(7):1444–1448. https://doi.org/10.1128/AAC.41.7.1444
- Jackson K, Locarnini S, Gish R. Diagnostics of Hepatitis B virus: standard of care and investigational. Clin Liver Dis (Hoboken). 2018 Jul;12(1):5–11. https://doi.org/10.1002/cld.729
- Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018 Nov 6;6(13):589–599. https://doi.org/10.12998/wjcc.v6.i13.589
- Jeng WJ, Sheen IS, Liaw YF. Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. Clin Gastroenterol Hepatol. 2010 Jun;8(6):541–545. https://doi.org/10.1016/j.cgh.2010.02.023
- Kim H, Lee SA, Do SY, Kim BJ. Precore/core region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol. 2016;22(17):4287–4296. https://doi.org/10.3748/wjg.v22.i17.4287
- Kırdar S, Yaşa MH, Sayan M, Aydın N. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment] (in Turkish). Mikrobiyol Bul. 2019;53(2):144–155. https://doi.org/10.5578/mb.67816
- Kmet Lunacek N, Poljak M, Meglic-Volkar J, Rajter M, Prah J, Lesnicar G, Selic Kurincic T, Baklan Z, Remec T, Pal E, et al. Epidemiological, virological and clinical characteristics of hepatitis B virus genotypes in chronically infected persons in Slovenia. Hepat Mon. 2017 Mar 04;17(3):e43838. https://doi.org/10.5812/hepatmon.43838
- Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, et al.; BEHoLD AI463027 Study Group. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006 Mar 09;354(10):1011–1020. https://doi.org/10.1056/NEJMoa051287
- Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS. Present and future therapies of hepatitis B: from discovery to cure. Hepatology. 2015 Dec;62(6):1893–1908. https://doi.org/10.1002/hep.28025
- Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver Int. 2016 Jan;36 Suppl 1:85–92. https://doi.org/10.1111/liv.13003
- Liu YP, Yao CY. Rapid and quantitative detection of hepatitis B virus. World J Gastroenterol. 2015;21(42):11954–11963. https://doi.org/10.3748/wjg.v21.i42.11954
- Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology. 2016 Jan;63(1):284–306. https://doi.org/10.1002/hep.28280
- Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology. 2009 Sep;50(3):661–662. https://doi.org/10.1002/hep.23190
- Mahmood M, Anwar MA, Khanum A, Zaman N, Raza A. Distribution and clinical significance of hepatitis B virus genotypes in Pakistan. BMC Gastroenterol. 2016 Dec;16(1):104. https://doi.org/10.1186/s12876-016-0513-5
- Malagnino V, Fofana DB, Lacombe K, Gozlan J. Occult hepatitis B virus infection: An old entity with novel clinical involvements. IDSA. 2018;5(10):ofy227. https://doi.org/10.1093/ofid/ofy227
- Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: what’s the future holding for us? World J Gastroenterol. 2015;21(44):12558–12575. https://doi.org/10.3748/wjg.v21.i44.12558
- McNaughton AL, D’Arienzo V, Ansari MA, Lumley SF, Littlejohn M, Revill P, McKeating JA, Matthews PC. Insights from deep sequencing of the HBV genome-Inique,tiny, and misunderstood. Gastroenterology. 2019 Jan;156(2):384–399. https://doi.org/10.1053/j.gastro.2018.07.058
- Mou Y, Athar MA, Wu Y, Xu Y, Wu J, Xu Z, Hayder Z, Khan S, Idrees M, Nasir MI, et al. Detection of anti-hepatitis B virus drug resistance mutations based o multicolor melting curve analysis. J Clin Microbiol. 2016 Nov;54(11):2661–2668. https://doi.org/10.1128/JCM.00439-16
- Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Häussinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med. 1996 May 30;334(22):1422–1427. https://doi.org/10.1056/NEJM199605303342202
- Otero W, Parga J, Gastelbondo J. Serology of hepatitis B virus: multiple scenarios and multiple exams. Rev Col Gastroenterol. 2018; 33(4):404–413. http://doi.org/10.22516/25007440.327
- Paudel D, Suvedi S. Hepatitis B genotyping and clinical implications. London (UK): IntechOpen; 2019. http://doi.org/10.5772/intechopen.82492
- Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol. 2014;20(23):7152–7168. https://doi.org/10.3748/wjg.v20.i23.7152
- Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017 Dec;67(6):1281–1297. https://doi.org/10.1016/j.jhep.2017.07.011
- Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen D-S, Van Damme P, Abbas Z, Abdulla M, Abou Rached A, Adda D, Aho I, et al.; Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018 Jun; 3(6):383–403. https://doi.org/10.1016/S2468-1253(18)30056-6
- Roman S. Occult hepatitis B and other unexplored risk factors for hepatocellular carcinoma in Latin America. Ann Hepatol. 2018 Jul; 17(4):541–543. https://doi.org/10.5604/01.3001.0012.0914
- Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res. 2004 Jul 01;32 Web Server:W654–W659. https://doi.org/10.1093/nar/gkh419
- Sayan M, Arikan A, Sanlidag T. Comparison of performance characteristics of DxN VERIS system versus Qiagen PCR for HBV genotype D and HCV genotype 1b quantification. Pol J Microbiol. 2019;68(1):139–143. https://doi.org/10.21307/pjm-2019-008
- Scaglione SJ, Lok AS. Effectiveness of hepatitis B treatment in clinical practice. Gastroenterol. 2012;142(6):1360–1368. https://doi.org/10.1053/j.gastro.2012.01.044
- Schreiber F. Phylogenetic sequence analysis. Methods course bioinformatics. 2007/08 [cited 2020]. Available from http://gobics.de/fabian/molbio_course/data/handout_phylogeny.pdf
- Shaha M, Sarker PK, Hossain MS, Das KC, Jahan M, Dey SK, Tabassum S, Hashem A, Salimullah M. Analysis of the complete genome of hepatitis B virus subgenotype C2 isolate NHB17965 from a HBV infected patient. F1000 Res. 2018;7:1023. https://doi.org/10.12688/f1000research.15090.3
- Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 Apr;67(4):1560–1599. https://doi.org/10.1002/hep.29800
- Than TT, Jo E, Todt D, Nguyen PH, Steinmann J, Steinmann E, Windisch MP. High environmental stability of Hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis. 2019 Mar 15;219(7):1044–1048. https://doi.org/10.1093/infdis/jiy620
- Tsuge M, Murakami E, Imamura M, Abe H, Miki D, Hiraga M, Takahashi S, et al. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of NA treatments in CHB patients. J Gastroenterol. 2013;48:1188–1204. https://doi.org/10.1007/s00535-012-0737-2
- Van Damme P. Long-term protection after hepatitis B vaccine. J Infect Dis. 2016 Jul 01;214(1):1–3. https://doi.org/10.1093/infdis/jiv750
- Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni LP. Update on hepatitis B and C virus diagnosis. World J Virol. 2015;4(4):323–342. https://doi.org/10.5501/wjv.v4.i4.323
- Wang J, Zhang P, Zeng J, Du P, Zheng X, Ye X, Zhu W, Fu Y, Candotti D, Allain JP, et al. Occurrence of occult hepatitis B virus infection associated with envelope protein mutations according to anti-HBs carriage in blood donors. Int J Infect Dis. 2020 Mar;92:38–45. https://doi.org/10.1016/j.ijid.2019.12.026
- Wang W, Shu Y, Bao H, Zhao W, Wang W, Wang Q, Lei X, Cui D, Yan Z. Genotypes and hot spot mutations of hepatitis B virus in northwest Chinese population and its correlation with disease progression. BioMed Res Int. 2019 Dec 10;2019:1–9. https://doi.org/10.1155/2019/3890962
- Wei W, Wu Q, Zhou J, Kong Y, You H. A better antiviral efficacy found in nucleos(t)ide analog (NA) combinations with interferon therapy than NA monotherapy for HBeAg positive chronic hepatitis B:A meta-analysis. Int J Environ Res Public Health. 2015 Aug 21; 12(8):10039–10055. https://doi.org/10.3390/ijerph120810039
- WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [Internet]. Geneva (Switzerland): World Health Organization; 2015 [cited 2020 Mar]. Available from https://www.ncbi.nlm.nih.gov/books/NBK305553/pdf/Bookshelf_ NBK305553.pdf
- WHO. Global Health Section Strategy on Viral Hepatitis 2016–2021 [Internet]. Geneva (Switzerland): World Health Organization; 2016 [cited 2020 Jun]. Available from https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=BB8 238CF4BF67C1B4A8A93329842962F?sequence=1
- WHO. Hepatitis B vaccination has dramatically reduced infection rates among children in Europe, but more is needed to achieve elimination [Internet]. Geneva (Switzerland): World Health Organization; 2017a [cited 2020 Mar]. Available from http://www.euro. who.int/en/health-topics/communicable-diseases/hepatitis/news/news/2017/04/hepatitis-b-vaccination-has-dramatically-reduced-infection-rates-among-children-in-europe,-but-more-is-needed-to-achieve-elimination
- WHO. Guidelines on hepatitis B and C testing [Internet]. Geneva (Switzerland): World Health Organization; 2017b [cited 2020 Jun]. Available from https://apps.who.int/iris/bitstream/handle/10665/254621/9789241549981-eng.pdf;jsessionid=A0864CBC8CC4C869 B57151EFE7359170?sequence=1
- WHO. Hepatitis B Key Facts [Internet]. Geneva (Switzerland): World Health Organization; 2019a [cited 2020 Jul]. Available from https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
- WHO. Hepatitis B in the WHO European region [Internet]. Geneva (Switzerland): World Health Organization; 2019b [cited 2020 Jul]. Available from http://www.euro.who.int/__data/assets/pdf_file/0007/377251/Fact-Sheet-Hepatitis-B_2019-ENG.pdf?ua=1
- WHO. Hepatitis D [Internet]. Geneva (Switzerland): World Health Organization; 2020 [cited 2020 Jul]. Available from https://www. who.int/news-room/fact-sheets/detail/hepatitis-d
- Wu IC, Liu WC, Chang TT. Applications of next generation sequencing analysis for the detection of hepatocellular carcinoma associated hepatitis B virus mutations. J Biomed Sci. 2018;25(51):1–12. https://doi.org/10.1186/s12929-018-0442-4